ALPN Live signals | Maximize Profits with Getagraph.com

SELL 452 min ago

@ $64.44

Issued: 19 Apr 2024 @ 13:31

Return: 0.18%

Previous signal: Apr 18 - 16:00

Previous signal: Buy

Return: 0.01 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.77% compare to its pairs and should correct upwards.

Stats
Today's Volume	3.98M
Average Volume	2.17M
Market Cap	4.23B
EPS	$0 ( 2024-03-18 )
Next earnings date	( $-0.430 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-100.86
ATR14	$0.0600 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-03	Fuhs Ulrich Martin	Sell	0	Common Stock
2024-04-03	Fuhs Ulrich Martin	Sell	75 000	Stock Option (Right to buy)
2024-04-03	Fuhs Ulrich Martin	Sell	28 700	Stock Option (Right to buy)
2024-04-03	Fuhs Ulrich Martin	Sell	14 600	Stock Option (Right to buy)
2024-01-25	Rickey James Paul	Sell	236	Stock Option (Right to buy)

INSIDER POWER
-21.38
Last 100 transactions
Buy: 4 566 792 \| Sell: 7 050 513

Correlation (AI algo v.1.1b): Undervalued: 0.77% $64.97 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.61 (weak)

Short: 0.13 (neutral)

Signal:(63) Neutral

Alpine Immune Sciences Correlation

10 Most Positive Correlations
FCNCA	0.951
IZEA	0.95
SZZL	0.949
MSDA	0.946
BOXL	0.945
VECO	0.945
APYX	0.943
PNNT	0.941
ESQ	0.94
BTWN	0.939

10 Most Negative Correlations
SILK	-0.944
PAYS	-0.936
AGRI	-0.934
ZSAN	-0.933
PRQR	-0.932
EBET	-0.932
TTCF	-0.931
TCFC	-0.924
IMBI	-0.923
FWBI	-0.919

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Alpine Immune Sciences Correlation - Currency/Commodity

0.37
( neutral )

0.05
( neutral )

0.00
( neutral )

-0.40
( neutral )

0.00
( neutral )

0.33
( neutral )

Alpine Immune Sciences Financials

Annual	2023
Revenue:	$58.88M
Gross Profit:	$58.30M (99.02 %)
EPS:	$-0.640

Q4	2023
Revenue:	$30.85M
Gross Profit:	$30.71M (99.52 %)
EPS:	$0.0988

Q3	2023
Revenue:	$10.04M
Gross Profit:	$9.90M (98.55 %)
EPS:	$-0.240

Q2	2023
Revenue:	$8.59M
Gross Profit:	$8.45M (98.35 %)
EPS:	$-0.270

Financial Reports:

No articles found.

Alpine Immune Sciences

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.